Form 4: Lemaitre Vascular Director Reports Stock Transactions

Lemaitre Vascular President and Director David B. Roberts reported recent stock transactions involving the vesting of restricted and performance stock units and associated tax withholdings.

Summary

• David B. Roberts, President and Director of Lemaitre Vascular Inc. (LMAT), reported multiple transactions on December 11 and 12, 2025.
• On December 11, 2025, Roberts acquired 25 shares of common stock upon the release of dividend equivalent rights (DERs) related to a restricted stock unit (RSU) award granted on December 11, 2021, at a price of $0.
• On December 11, 2025, 297 shares were disposed of by the Issuer at a price of $83.36 to satisfy tax withholding obligations incurred upon the vesting of the RSU award granted on December 11, 2021.
• On December 12, 2025, Roberts acquired 18 shares of common stock upon the release of DERs related to an RSU award granted on December 12, 2022, at a price of $0.
• Also on December 12, 2025, Roberts acquired another 18 shares of common stock upon the release of DERs related to a performance stock unit (PSU) award granted on December 12, 2022, at a price of $0.
• On December 12, 2025, 302 shares were disposed of by the Issuer at a price of $84 to satisfy tax withholding obligations incurred upon the vesting of the RSU award granted on December 12, 2022.
• Additionally, on December 12, 2025, another 302 shares were disposed of by the Issuer at a price of $84 to satisfy tax withholding obligations incurred upon the vesting of the PSU award granted on December 12, 2022.
• All dispositions for tax withholding were considered exempt sales pursuant to Rule 16b-3(e).
• Following these reported transactions, David B. Roberts beneficially owns 22,251 shares of Lemaitre Vascular Inc. common stock.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions related to executive compensation, specifically the vesting of equity awards and associated tax withholdings. These are expected events and do not indicate a significant positive or negative shift in the company's outlook or the insider's sentiment beyond the standard compensation structure.

Positives

• The vesting of restricted and performance stock units indicates the achievement of performance milestones or continued service by the reporting person.
• The acquisition of shares from dividend equivalent rights at a $0 cost represents a direct benefit to the reporting person.

Negatives

• A total of 801 shares were disposed of to cover tax withholding obligations, which reduces the direct beneficial ownership of the reporting person.

Future Outlook

NA

Industry Context

This filing details routine insider transactions related to executive compensation, which are common across all industries for publicly traded companies. It does not provide specific insights into broader industry trends for the medical device sector.

Related Party Transactions

• The disposition of shares by the reporting person to the Issuer to satisfy tax withholding obligations is a transaction between a related party (officer/director) and the company.

Stakeholder Impact

• Shareholders: Minimal direct impact as these are routine compensation-related transactions, not voluntary open-market sales or purchases that would signal a change in insider sentiment.
• Employees: Reflects the standard operation of the company's equity compensation plans for executives.

Key Dates

Keywords

Lemaitre Vascular, LMAT, Form 4, Insider Transaction, Executive Compensation, Restricted Stock Units, Performance Stock Units, Dividend Equivalent Rights, Stock Vesting, Tax Withholding